Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Overcoming the Blood-Brain Barrier in Neurodegenerative Disorders and Brain Tumours Publisher Pubmed



Ebrahimi Z1 ; Talaei S2 ; Aghamiri S3, 4 ; Goradel NH5 ; Jafarpour A6 ; Negahdari B5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Students' Scientific Research Center, Virology Division, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: IET Nanobiotechnology Published:2020


Abstract

Drug delivery is one of the major challenges in the treatment of central nervous system disorders. The brain needs to be protected from harmful agents, which are done by the capillary network, the so-called blood-brain barrier (BBB). This protective guard also prevents the delivery of therapeutic agents to the brain and limits the effectiveness of treatment. For this reason, various strategies have been explored by scientists for overcoming the BBB from disruption of the BBB to targeted delivery of nanoparticles (NPs) and cells and immunotherapy. In this review, different promising brain drug delivery strategies including disruption of tight junctions in the BBB, enhanced transcellular transport by peptide-based delivery, local delivery strategies, NP delivery, and cell-based delivery have been fully discussed. © The Institution of Engineering and Technology 2020
Related Docs
View other Related Docs
1. Nonviral Sirna Delivery Systems for Pancreatic Cancer Therapy, Biotechnology and Bioengineering (2021)
2. In Vitro Models and Systems for Evaluating the Dynamics of Drug Delivery to the Healthy and Diseased Brain, Journal of Controlled Release (2018)
3. Recent Advances in Sirna Delivery Systems for Prostate Cancer Therapy, Current Pharmaceutical Biotechnology (2022)
4. Antimicrobial Peptides: A Promising Strategy for Lung Cancer Drug Discovery?, Expert Opinion on Drug Discovery (2020)
5. Nanotechnology-Based Theranostic Approaches in Brain Diseases, Theranostics Nanomaterials in Drug Delivery (2024)
6. Preparation and Investigation of Indirubin-Loaded Sln Nanoparticles and Their Anti-Cancer Effects on Human Glioblastoma U87mg Cells, Cell Biology International (2019)
7. Nanoparticles in Cancer Theranostics: Focus on Gliomas, BioNanoScience (2025)
8. Delivery of Genome Editing Tools: A Promising Strategy for Hpv-Related Cervical Malignancy Therapy, Expert Opinion on Drug Delivery (2020)
Experts (# of related papers)
View all Related Experts
Rassoul Dinarvand (3)
Gholamreza Hassanzadeh (2)
Other Related Docs
9. Antimicrobial Peptides As Potential Therapeutics for Breast Cancer, Pharmacological Research (2021)
10. Potential Application of Liposomal Nanodevices for Non-Cancer Diseases: An Update on Design, Characterization and Biopharmaceutical Evaluation, Advances in Colloid and Interface Science (2020)
11. Oncolytic Virotherapy: Challenges and Solutions, Current Problems in Cancer (2021)
12. Preparation of Surface-Modified Plga Nanoparticles Containing Carbon Quantum Dots: Insights From C6 Cell Line Assays, Nanomedicine (2025)
13. Ignoring the Modeling Approaches: Towards the Shadowy Paths in Nanomedicine, Journal of Controlled Release (2018)
14. Maternal Exposure to Silver Nanoparticles Are Associated With Behavioral Abnormalities in Adulthood: Role of Mitochondria and Innate Immunity in Developmental Toxicity, NeuroToxicology (2018)
15. Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases, International Journal of Nanomedicine (2022)
16. Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers As New Generations of Blood-Brain Barrier Transmitters, ACS Chemical Neuroscience (2021)
17. Wharton’S Jelly Mesenchymal Stem Cells Attenuate Global Hypoxia-Induced Learning and Memory Impairment Via Preventing Blood-Brain Barrier Breakdown, Iranian Journal of Basic Medical Sciences (2023)
18. An Update on Actively Targeted Liposomes in Advanced Drug Delivery to Glioma, International Journal of Pharmaceutics (2021)
19. Curcumin-Lipoic Acid Conjugate As a Promising Anticancer Agent on the Surface of Gold‑Iron Oxide Nanocomposites: A Ph-Sensitive Targeted Drug Delivery System for Brain Cancer Theranostics, European Journal of Pharmaceutical Sciences (2018)
20. Biology, Pathology, and Targeted Therapy of Exosomal Cargoes in Parkinson’S Disease: Advances and Challenges, Molecular Neurobiology (2025)
21. Extracellular Vesicles As a Neprilysin Delivery System Memory Improvement in Alzheimer’S Disease, Iranian Journal of Pharmaceutical Research (2020)
22. Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases, Journal of Molecular Neuroscience (2022)
23. Autophagy, a Critical Element in the Aging Male Reproductive Disorders and Prostate Cancer: A Therapeutic Point of View, Reproductive Biology and Endocrinology (2023)